SR
Sunil Rajanikant Mehta
About Sunil Rajanikant Mehta
Data last updated:
Sunil Rajanikant Mehta is a Whole-Time Director at Emcure Pharmaceuticals Limited (since 2013) and Director at Gennova Biopharmaceuticals Limited (since 2001). The companies operate in Pharma, Life Sciences and Paper. The 2 current companies with reported revenue have a combined latest revenue of ₹9,593 Cr; the largest is Emcure Pharmaceuticals Limited at ₹9,216 Cr (FY 2026). Earlier, Sunil Rajanikant Mehta was a Director at Emcutix Biopharmaceuticals Limited (2024) and Partner at Dolat Absolute Return Llp (2021) and 3 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 05 Jun 2013 | 1981 | ₹9,216 Cr (FY 2026) | Active | |
| Director | 19 Jun 2001 | 2001 | ₹376 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Oct 2024 | 2024 | ₹11.88 Cr (FY 2025) | Active | |
| Partner | 29 Jan 2021 | 2020 | ₹37.07 Cr (FY 2025) | Active | |
| Director | 01 Jun 2005 | 2005 | Amalgamated | ||
| Director | 26 Aug 2020 | 2020 | ₹1,801 Cr (FY 2025) | Active | |
| Director | 15 Jan 2001 | 2000 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sunil Rajanikant Mehta
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunil Rajanikant Mehta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunil Rajanikant Mehta
Sunil Rajanikant Mehta currently holds 2 directorships: Emcure Pharmaceuticals Limited (Whole-Time Director, since 05 Jun 2013, revenue ₹9,216 Cr (FY 2026)); Gennova Biopharmaceuticals Limited (Director, since 19 Jun 2001, revenue ₹376 Cr (FY 2023)).
Sunil Rajanikant Mehta was first appointed on 15 Jan 2001 as Director at Emcure Infotech Limited. The most recent appointment on record is 03 Oct 2024 at Emcutix Biopharmaceuticals Limited.
The 2 current companies of Sunil Rajanikant Mehta that report revenue have a combined latest revenue of ₹9,593 Cr: Emcure Pharmaceuticals Limited ₹9,216 Cr (FY 2026); Gennova Biopharmaceuticals Limited ₹376 Cr (FY 2023).
Sunil Rajanikant Mehta held 5 earlier board appointments: Emcutix Biopharmaceuticals Limited (Director, 03 Oct 2024 to 19 Dec 2024); Dolat Absolute Return Llp (Partner, 29 Jan 2021 to 25 Nov 2021); Lasor Pharmaceuticals Limited (Director, 01 Jun 2005 to 04 Feb 2010); Avet Lifesciences Private Limited (Director, 26 Aug 2020 to 23 Jul 2021); Emcure Infotech Limited (Director, from 15 Jan 2001).
The current boards of Sunil Rajanikant Mehta's companies include Amruta Balchandra Jana (Emcure Pharmaceuticals Limited), Chinnadharavaram Sundaresan Muralidharan (Emcure Pharmaceuticals Limited), Mukund Keshao Gurjar (Emcure Pharmaceuticals Limited), Namita Vikas Thapar (Emcure Pharmaceuticals Limited), Raman Pillai Raghu Kumar (Emcure Pharmaceuticals Limited), Samit Satish Mehta (Emcure Pharmaceuticals Limited), among others.